The USP GMP certificate recognizes that the facilities operate GMP quality systems which meet the requirements set forth in 21 CFR Part 117 Current Good Manufacturing Practice, Hazard Analysis and Risk-Based Preventive Controls for Human Food, and USP-NF General Chapter 2750 Manufacturing Practices for Dietary Supplements for Dietary Ingredient Manufacturing.
These state-of-the-art cGMP manufacturing units produce a range of Sabinsa’s ingredients, from standardized botanical extracts to nutritional and specialty fine chemicals, for the food, beverage, dietary supplement, cosmeceutical and pharma industries, according to Sabinsa.
The Kunigal and Hyderabad units are equipped to handle batch extractions, whereas the Dobaspet unit is a unique facility with continuous extractors made entirely of Stainless Steel (SS) 316 which can extract more than 40 tons of herbal raw material a day. The plant has scale and size to continuously extract oleoresin from herbal raw material.
“We’re pleased to have this assurance from USP reaffirm that our manufacturing facilities comply with US cGMP requirements,” said Sabinsa founder Dr. Muhammed Majeed. “While we welcome and encourage customers to tour our facilities, USP audits can be reassuring for those not able to do so in person.”
“USP is pleased to recognize Sabinsa’s successful completion of the USP Quality Systems GMP Audit Program for this facility,” said John Atwater, senior director of USP Verification Services. “This demonstrates Sabinsa’s commitment to quality and to operating GMP quality systems for the manufacture of dietary ingredients in compliance with officially recognized requirements.”